Ready, Set, Action: Collaborative Management to Improve Diagnosis of Alzheimer Disease
Released On
December 07, 2022
Expires On
December 07, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Geriatric Medicine, Neurology, Internal Medicine, Primary Care
Topic(s)
Alzheimer's, Geriatric Medicine, Dementia
Scroll to the Bottom of this Information to Begin this Course
Sponsored by Academy for Continued Healthcare Learning (ACHL).
This activity is supported by educational grants from Lilly and Genentech, a member of Roche Group.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is designed for primary care physicians, internists, geriatricians, neurologists, and NPs and PAs who care for patients with or at risk for AD
Program Overview
It can be a struggle to diagnose Alzheimer disease (AD), but it is worth the time and effort! The benefits of a timely diagnosis for both patients and families cannot be overstated. Do you have questions about appropriate tests you can use in daily practice? Do you do cognitive, imaging, and/or biomarker tests when you suspect AD? Do you sometimes wonder how to talk about AD and diagnostic tests with patients and family members? In this innovative “cinemeducation” format, you will see representative interactions that model best practices. Ready, Set, Action…access this novel educational activity today!
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify the symptoms of Alzheimer disease to differentiate it from other neurodegenerative disorders and normal aging to gain confidence in making a diagnosis
- Employ and interpret appropriate cognitive, biomarker, and imaging tests in clinical practice to improve diagnosis of Alzheimer disease
- Describe the benefits of earlier diagnosis of Alzheimer disease for patients and caregivers
Activity Purpose
Alzheimer disease (AD) is characterized by declines in memory, language, problem-solving, and other cognitive abilities necessary for performance of daily activities, and is associated with a significant burden for patients, their caregivers, and society. However, detection of AD remains suboptimal with many patients not diagnosed, misdiagnosed, or experiencing a delay in diagnosis. Consequently, there is a significant educational need in identification of symptoms and differential diagnosis; the importance of early diagnosis; and appropriate testing methodologies (ie, cognitive, imaging, and biomarker assessments) and their interpretation. To improve diagnostic practices across the spectrum of care, this activity employs “cinemeducation” to illustrate and model best practices. In this case-based experience, patient/caregiver interactions with physicians are shown, with expert faculty commentary on ways to improve these interactions and enhance the diagnosis of AD.
Faculty
Andrew E. Budson, MD
Chief, Cognitive and Behavioral Neurology, VA Boston Healthcare System
Associate Director and Outreach, Recruitment, & Engagement Core Leader, Boston University Alzheimer’s Disease Research Center
Professor of Neurology, Boston University School of Medicine
Lecturer in Neurology, Harvard Medical School
Boston, MA
Physician Accreditation Statement
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians
Physician Credit Designation
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclaimer
The content for this activity was developed independently of the ineligible companies. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
Disclosures of Conflicts of Interest
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
- Andrew E. Budson, MD
-
- Advisor or Review Panel member: Lilly, Genentech
- Speakers' Bureau: Lilly
- Royalty recipient: Oxford University Press, Elsevier
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Blood tests for beta-amyloid, tau, neurofilament light chain, and glial fibrillary acidic protein are not approved by the FDA.
Instructions for Participation and Credit
This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Karen Catino at kcatino@achlcme.org
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above